A Silicon Valley genome sciences startup has joined an initiative to help doctors interpret the risks associated with gene variants linked to breast and ovarian cancer.
Syapse develops software platforms for aggregating and structuring medical data, including genomic information, that is collected by diagnostic companies, biotech and hospitals. The idea is to create medical records that are savvy to genomics and other data-intensive biomedical information–so that doctors can better diagnose and treat patients using that data.
One way such medical records could achieve that goal is by promoting data sharing. At this early stage of medical genomics, doctors may not always know how a particular DNA variant can affect their patients’ health. What’s needed is a common database that links DNA variants to medical outcomes.